On July 24, 2023, Salona Global Medical Device Corporation (the Company) appointed Michael Seckler, 58, to the position of Chief Executive Officer. From June 13, 2023 through July 24, 2023, Mr. Seckler served as Interim Chief Executive Officer of the Company. From October 2022 through May 2023, Mr. Seckler served as Chief Operating Officer and from January 2020 through September 2022, Mr. Seckler served as Senior Vice President of FerGene, a gene therapy company affiliated with Ferring International Center, SA, a Swiss multinational biopharmaceutical company (Ferring).

From January 2017 through December 2019, Mr. Seckler was Vice President of Global Marketing and Corporate Communications at Ferring.